Detalles de la búsqueda
1.
Guselkumab for the Treatment of Crohn's Disease: Induction Results From the Phase 2 GALAXI-1 Study.
Gastroenterology
; 162(6): 1650-1664.e8, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35134323
2.
Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial.
Lancet Gastroenterol Hepatol
; 9(2): 133-146, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38104569
3.
Efficacy and safety of glucagon-like peptide-1/glucagon receptor co-agonist JNJ-64565111 in individuals with obesity without type 2 diabetes mellitus: A randomized dose-ranging study.
Clin Obes
; 11(2): e12432, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33475255
4.
Fulranumab in Patients With Pain Associated With Postherpetic Neuralgia and Postraumatic Neuropathy: Efficacy, Safety, and Tolerability Results From a Randomized, Double-blind, Placebo-controlled, Phase-2 Study.
Clin J Pain
; 33(2): 99-108, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27153360
5.
Coadministration of Canagliflozin and Phentermine for Weight Management in Overweight and Obese Individuals Without Diabetes: A Randomized Clinical Trial.
Diabetes Care
; 40(5): 632-639, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28289041
6.
A randomized study to evaluate the analgesic efficacy of a single dose of the TRPV1 antagonist mavatrep in patients with osteoarthritis.
Scand J Pain
; 17: 134-143, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28850367
7.
A randomized, double-blind, placebo-controlled 12 week trial of acetaminophen extended release for the treatment of signs and symptoms of osteoarthritis.
Curr Med Res Opin
; 30(11): 2377-87, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25121804
8.
Fulranumab for treatment of diabetic peripheral neuropathic pain: A randomized controlled trial.
Neurology
; 83(7): 628-37, 2014 Aug 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-25008392
Resultados
1 -
8
de 8
1
Próxima >
>>